TY - JOUR
T1 - A modular PROTAC design for target destruction using a degradation signal based on a single amino acid
AU - Shanmugasundaram, Karthigayan
AU - Shao, Peng
AU - Chen, Han
AU - Campos, Bismarck
AU - McHardy, Stanton F.
AU - Luo, Tuoping
AU - Rao, Hai
N1 - Publisher Copyright:
© 2019 American Society for Biochemistry and Molecular Biology Inc.. All rights reserved.
PY - 2019/10/11
Y1 - 2019/10/11
N2 - Proteolysis targeting chimeras (PROTACs) are bivalent molecules that bring a cellular protein to a ubiquitin ligase E3 for ubiquitination and subsequent degradation. Although PROTAC has emerged as a promising therapeutic means for cancers as it rewires the ubiquitin pathway to destroy key cancer regulators, the degradation signals/pathways for PROTACs remain underdeveloped. Here we append single amino acids, the simplest degradation signal, to a ligand specific for estrogen-related receptor (ERR) and demonstrate their utility in ERR knockdown via the N-end rule pathway and also their efficiency in the growth inhibition of breast cancer cells. The modular design described offers unique advantages including smaller molecular size with shortest degradation sequences and degradation speed modulation with different amino acids. Our study expands the repertoire of limited ubiquitin pathways currently available for PROTACs and could be easily adapted for broad use in targeted protein degradation.
AB - Proteolysis targeting chimeras (PROTACs) are bivalent molecules that bring a cellular protein to a ubiquitin ligase E3 for ubiquitination and subsequent degradation. Although PROTAC has emerged as a promising therapeutic means for cancers as it rewires the ubiquitin pathway to destroy key cancer regulators, the degradation signals/pathways for PROTACs remain underdeveloped. Here we append single amino acids, the simplest degradation signal, to a ligand specific for estrogen-related receptor (ERR) and demonstrate their utility in ERR knockdown via the N-end rule pathway and also their efficiency in the growth inhibition of breast cancer cells. The modular design described offers unique advantages including smaller molecular size with shortest degradation sequences and degradation speed modulation with different amino acids. Our study expands the repertoire of limited ubiquitin pathways currently available for PROTACs and could be easily adapted for broad use in targeted protein degradation.
UR - http://www.scopus.com/inward/record.url?scp=85073183232&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85073183232&partnerID=8YFLogxK
U2 - 10.1074/jbc.AC119.010790
DO - 10.1074/jbc.AC119.010790
M3 - Article
C2 - 31511327
AN - SCOPUS:85073183232
SN - 0021-9258
VL - 294
SP - 15172
EP - 15175
JO - Journal of Biological Chemistry
JF - Journal of Biological Chemistry
IS - 41
ER -